GlassScriptPhysician profile
Jason A Crawford
NPI 1124148002
$3,446.36
in general payments reported to CMS, 2019-2025
11 companies · $729 in 2025
The $729 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.60 · 2020: $25.20 · 2021: $75.64 · 2022: $153 · 2023: $187 · 2024: $2,215 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $1,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $1,131.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,180.68 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Tarsus Pharmaceuticals, INC. | $373.13 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $244.02 | 2024-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $217.44 | 2020-2025 | Cequa |
| Bausch & Lomb Americas INC. | $114.02 | 2023-2025 | Xiidra, Miebo, Infuse |
| Johnson & Johnson Vision Care, INC. | $81.30 | 2019-2025 | Acuvue |
| Novartis Pharmaceuticals Corporation | $71.40 | 2022-2023 | |
| Coopervision INC. | $70.19 | 2022-2025 | Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.86 | 2019-2021 | |
| Allergan, INC. | $33.50 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $14.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Crawford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.